Download | < Back |
03 Aug 2022 | |
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we herein mention the schedule of Analyst/Institutional Investor Meeting with the Company. | |
View all announcements for AJANTA PHARMA LTD. | Source: BSE India |